Timothy W Synold (Timothy Synold)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Bioanalysis

Nature communications

Cancer gene therapy

Beckman Research Institute, City of Hope

University of California Santa Barbara (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Beckman Research Institute, City of Hope

United States

Professor and Director :: Division of Molecular Pharmacology

Beckman Research Institute, City of Hope

United States

Scientific Leader :: Phase I and Experimental Therapeutics Program

Beckman Research Institute, City of Hope

United States

Director :: Analytical Pharmacology Core Facility

Beckman Research Institute, City of Hope

United States

Professor :: Department of Molecular Pharmacology

Beckman Research Institute, City of Hope

United States

Director :: Clinical Immunobiology Correlative Studies Laboratory

Beckman Research Institute, City of Hope

United States

Associate Professor :: Department of Medical Oncology and Therapeutics Research

Beckman Research Institute, City of Hope

United States

Assistant Professor :: Department of Medical Oncology and Therapeutics Research

Beckman Research Institute, City of Hope

United States

Assistant Research Scientist :: Department of Medical Oncology and Therapeutics Research

Education History

University of California Santa Barbara

United States

BSC :: Chemistry

Publications

Ye Feng, Haider Mahdi, Richard Piekarz, Jan H Beumer, Timothy W Synold
An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma. Bioanalysis (2024)
Ye Feng, Haider Mahdi, Richard Piekarz, Jan H Beumer, Timothy W Synold
An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma. Bioanalysis 16 (8) (2024)
Ye Feng, Haider Mahdi, Richard Piekarz, Jan H Beumer, Timothy W Synold
An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma. Bioanalysis 16 (8) (2024)
Ye Feng, Haider Mahdi, Richard Piekarz, Jan H Beumer, Timothy W Synold
An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma. Bioanalysis 16 (8) (2024)
Ye Feng, Haider Mahdi, Richard Piekarz, Jan H Beumer, Timothy W Synold
An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma. Bioanalysis 16 (8) (2024)
Ye Feng, Erminia Massarelli, Eric Forman, John S Kovach, Ravi Salgia, Timothy W Synold
An LC-MS/MS method for simultaneous determination of LB-100 and its active metabolite, endothall, in human plasma. Bioanalysis (2023)
Rena Emond, Jason I Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F Medina, Rachel S Sousa, Timothy W Synold, Frederick R Adler, Andrea H Bild
Cell facilitation promotes growth and survival under drug pressure in breast cancer. Nature communications 14 (1) (2023)
Rena Emond, Jason I Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F Medina, Rachel S Sousa, Timothy W Synold, Frederick R Adler, Andrea H Bild
Cell facilitation promotes growth and survival under drug pressure in breast cancer. Nature communications 14 (1) (2023)
Rena Emond, Jason I Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F Medina, Rachel S Sousa, Timothy W Synold, Frederick R Adler, Andrea H Bild
Cell facilitation promotes growth and survival under drug pressure in breast cancer. Nature communications 14 (1) (2023)
Jana Portnow, Behnam Badie, M Suzette Blanchard, Julie Kilpatrick, Revathiswari Tirughana, Marianne Metz, Shu Mi, Vivi Tran, Julie Ressler, Massimo D'Apuzzo, Karen S Aboody, Timothy W Synold
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients. Cancer gene therapy 28 (3-4) (2020)

Timothy W Synold.css-eqlu8i{font-size:small;padding-left:4px;} (Timothy Synold)

Publication Activity (10 Years)

Top Topics

Top Venues

Timothy W Synold (Timothy Synold)